Author

Anthony Tran

University of California, San FranciscoORCID 0000-0002-5570-6436Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Abiola F. OgunsolaiD· 1 shared Artur Queiroz· 1 shared Bruno B. AndradeiD· 1 shared Cecilia S. Lindestam ArlehamniD· 1 shared Cheryl L. DayiD· 1 shared Devin Columbus· 1 shared Eduardo Rocha FukutaniiD· 1 shared Gillian BeameriD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Abiola F. OgunsolaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BCG vaccination elicits protection against Mtb infection mediated by two phases of T cell immunity

Abiola F. Ogunsola, Rocky Lai, Kelly Cavallo, Anthony Tran, Gillian Beamer, Samuel M. Behar

This study shows BCG vaccination protects against Mtb infection in CC042 mice through two T cell-dependent phases: an early innate response and a later effector T cell response.

JCI Insight · Jul 2, 2026Peer-reviewedImmunology

Rare Variable M. tuberculosis Antigens induce predominant Th17 responses in human infection

Paul Ogongo, Liya Wassie, Anthony Tran, Devin Columbus, Julia Huffaker, Lisa Sharling, Gregory Sadat Ouma, Samuel Gurrion Ouma, Kidist Bobosha, Cecilia S. Lindestam Arlehamn, Neel R. Gandhi, Sara C. Auld, Jyothi Rengarajan, Cheryl L. Day, Artur Queiroz, , the TBRU ASTRa Study Group

The paper identifies Rare Variable Mtb Antigens (RVMA) that induce Th17 responses in human TB infection, suggesting their potential as vaccine antigens to enhance Th17 immunity.

JCI Insight · Jan 27, 2026Peer-reviewedImmunology